Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters











Publication year range
1.
IEEE J Transl Eng Health Med ; 12: 298-305, 2024.
Article in English | MEDLINE | ID: mdl-38410184

ABSTRACT

OBJECTIVE: Metabolic changes have been extensively documented in neurodegenerative brain disorders, including Parkinson's disease and Alzheimer's disease (AD). Mutations in the C. elegans swip-10 gene result in dopamine (DA) dependent motor dysfunction accompanied by DA neuron degeneration. Recently, the putative human ortholog of swip-10 (MBLAC1) was implicated as a risk factor in AD, a disorder that, like PD, has been associated with mitochondrial dysfunction. Interestingly, the AD risk associated with MBLAC1 arises in subjects with cardiovascular morbidity, suggesting a broader functional insult arising from reduced MBLAC1 protein expression and one possibly linked to metabolic alterations. METHODS: Our current studies, utilizing Mblac1 knockout (KO) mice, seek to determine whether mitochondrial respiration is affected in the peripheral tissues of these mice. We quantified the levels of mitochondrial coenzymes, NADH, FAD, and their redox ratio (NADH/FAD, RR) in livers and kidneys of wild-type (WT) mice and their homozygous KO littermates of males and females, using 3D optical cryo-imaging. RESULTS: Compared to WT, the RR of livers from KO mice was significantly reduced, without an apparent sex effect, driven predominantly by significantly lower NADH levels. In contrast, no genotype and sex differences were observed in kidney samples. Serum analyses of WT and KO mice revealed significantly elevated glucose levels in young and aged KO adults and diminished cholesterol levels in the aged KOs, consistent with liver dysfunction. DISCUSSION/CONCLUSION: As seen with C. elegans swip-10 mutants, loss of MBLAC1 protein results in metabolic changes that are not restricted to neural cells and are consistent with the presence of peripheral comorbidities accompanying neurodegenerative disease in cases where MBLAC1 expression changes impact risk.


Subject(s)
Caenorhabditis elegans , Neurodegenerative Diseases , Animals , Female , Humans , Mice , Male , Aged , Mice, Knockout , Caenorhabditis elegans/genetics , Neurodegenerative Diseases/diagnostic imaging , NAD/metabolism , Dopaminergic Neurons/metabolism , Optical Imaging
2.
J Am Assoc Lab Anim Sci ; 59(5): 557-566, 2020 09 01.
Article in English | MEDLINE | ID: mdl-32693866

ABSTRACT

The Northern greater galago (Otolemur garnettii) is a prosimian primate most commonly used to study the evolutionary development of vision and somatosensation. This study aimed to investigate the efficacy and cardiopulmonary effects of 3 sedation protocols commonly used in other primate species: 1) alfaxalone (Alf; 8 mg/kg IM) 2) ketamine alone (Ket; 20 mg/kg IM) and 3) ketamine + dexmedetomidine (Ket+Dex; 4 mg/kg + 25 µg/kg IM) with reversal (atipamezole; 250 µg/kg IM). A total of 34 animals were evaluated, including 11 juveniles and 23 adults. Cardiopulmonary parameters such as indirect blood pressure, heart rate, respiratory rate, and SpO2 were measured, and blood was collected for blood gas analysis and a chemistry panel. To examine the efficacy of each sedation protocol, induction time, immobilization time, and recovery time were recorded. Subjective measures of quality and efficacy included quality of induction, pedal withdrawal reflex, palpebral reflex, muscle tension, rectal temperature, and quality of recovery. All 3 protocols successfully immobilized the animals and all animals recovered from sedation. Heart rates were highest among the Ket group and the lowest for the Ket+Dex group. On average, the Alf group was immobilized for twice as long as either the Ket or Ket+Dex groups. The Ket+Dex group had the fastest average recovery time and subjectively had the best quality of recovery. Based on these results, Ket+Dex is recommended over Alf or Ket alone for brief sedation of healthy galagos.


Subject(s)
Anesthesia/veterinary , Dexmedetomidine/pharmacology , Galagidae , Ketamine/pharmacology , Pregnanediones/pharmacology , Adrenergic alpha-2 Receptor Antagonists/administration & dosage , Adrenergic alpha-2 Receptor Antagonists/pharmacology , Anesthetics/administration & dosage , Anesthetics/pharmacology , Animals , Blood Pressure/drug effects , Dexmedetomidine/administration & dosage , Female , Heart Rate/drug effects , Hypnotics and Sedatives/administration & dosage , Hypnotics and Sedatives/pharmacology , Imidazoles/pharmacology , Ketamine/administration & dosage , Male , Pregnanediones/administration & dosage
3.
J Med Primatol ; 48(6): 374-377, 2019 12.
Article in English | MEDLINE | ID: mdl-31148179

ABSTRACT

Benign and malignant pulmonary tumors have been reported in both Old World and New World monkeys but are uncommon. Hemangiomas are also rarely reported in nonhuman primates. Here we present a case of two primary neoplasms (a papillary adenocarcinoma of bronchioloalveolar origin and multiple cavernous subcutaneous hemangiomas) arising in an aged squirrel monkey (Saimiri sciureus).


Subject(s)
Adenocarcinoma of Lung/veterinary , Hemangioma, Cavernous/veterinary , Lung Neoplasms/veterinary , Monkey Diseases/pathology , Saimiri , Adenocarcinoma of Lung/diagnosis , Adenocarcinoma of Lung/pathology , Animals , Diagnosis, Differential , Hemangioma, Cavernous/diagnosis , Hemangioma, Cavernous/pathology , Lung Neoplasms/diagnosis , Lung Neoplasms/pathology , Male , Monkey Diseases/diagnosis
4.
Comp Med ; 68(4): 256-260, 2018 08 01.
Article in English | MEDLINE | ID: mdl-30017019

ABSTRACT

Female nude mice (J:NU-Foxn1nu; age, 6 wk) were injected with 1 million MCF7 human breast cancer cells in the fourth mammary fat pads and received a 21-d sustained-release estrogen pellet (0.25 mg) subcutaneously in the dorsum of the neck. All mice were maintained in sterile housing and provided sterile water and irradiated rodent chow. Approximately 6 wk after implantation, 4 of the 30 mice showed clinical signs of depression and dehydration. The 2 animals most severely affected were euthanized and presented for necropsy. The urinary bladders of these animals were distended with variable sized white, opaque uroliths. Urinalysis revealed coccal bacteria, erythrocytes, neutrophils and struvite crystals. Urine cultures from both necropsied animals grew heavy, pure growths of Staphylococcus xylosus. The organism was sensitive to all antibiotics tested except erythromycin (intermediate). Analysis of the uroliths revealed 100% struvite composition. Remaining mice in the study were evaluated clinically for hydration status, the ability to urinate, and the presence of palpable stones in the urinary bladder; one additional mouse had a firm, nonpainful bladder (urolithiasis suspected). Given the sensitivity of the organisms cultured from urine samples, the remaining mice were placed on enrofloxacin in the drinking water (0.5 mg/mL). All remaining mice completed the study without further morbidity or mortality. Previous studies have reported the association of estrogen supplementation with urinary bladder pathology, including infection and urolithiasis. Here we present a case of urolithiasis and cystitis in nude mice receiving estrogen supplementation that was associated with Staphylococcus xylosus, which previously was unreported in this context. When assessing these nude mice for urolithiasis, we found that visualizing the stones through the body wall, bladder palpation, and bladder expression were helpful in identifying affected mice.


Subject(s)
Cystitis/microbiology , Staphylococcus/isolation & purification , Urolithiasis/microbiology , Animals , Cystitis/pathology , Estrogens/pharmacology , Female , Humans , MCF-7 Cells , Mice , Mice, Nude , Struvite , Urolithiasis/pathology
5.
Proc Natl Acad Sci U S A ; 114(32): E6652-E6659, 2017 08 08.
Article in English | MEDLINE | ID: mdl-28739897

ABSTRACT

Gram-positive bacteria cause the majority of skin and soft tissue infections (SSTIs), resulting in the most common reason for clinic visits in the United States. Recently, it was discovered that Gram-positive pathogens use a unique heme biosynthesis pathway, which implicates this pathway as a target for development of antibacterial therapies. We report here the identification of a small-molecule activator of coproporphyrinogen oxidase (CgoX) from Gram-positive bacteria, an enzyme essential for heme biosynthesis. Activation of CgoX induces accumulation of coproporphyrin III and leads to photosensitization of Gram-positive pathogens. In combination with light, CgoX activation reduces bacterial burden in murine models of SSTI. Thus, small-molecule activation of CgoX represents an effective strategy for the development of light-based antimicrobial therapies.


Subject(s)
Bacterial Proteins/metabolism , Coproporphyrinogen Oxidase/metabolism , Coproporphyrins/biosynthesis , Photosensitizing Agents/metabolism , Phototherapy , Staphylococcal Skin Infections/enzymology , Staphylococcal Skin Infections/therapy , Staphylococcus aureus/metabolism , Animals , Bacterial Proteins/genetics , Coproporphyrinogen Oxidase/genetics , Coproporphyrins/genetics , Disease Models, Animal , Mice , Staphylococcus aureus/genetics
6.
Comp Med ; 66(5): 424-428, 2016.
Article in English | MEDLINE | ID: mdl-27780011

ABSTRACT

In humans, phyllodes tumors of the breast are rare fibroepithelial tumors that are further characterized as benign, borderline, or malignant according to their histomorphologic features. Phyllodes tumors are poorly responsive to treatment other than excision. NHP have a much lower frequency of mammary neoplasia than do humans, and none of the lesions reported previously in NHP are consistent with phyllodes tumors. Here we present the case of a mammary tumor in a northern greater galago (Otolemur garnettii) that was histologically characteristic of a malignant phyllodes tumor. An 11-y-old, multiparous, pregnant galago presented with a mass in the right middle mammary gland. A fine-needle aspirate yielded neoplastic epithelial cells. Because the animal was pregnant and showed no signs of skin ulceration, pain, or distress, she was allowed to deliver and nurse the infant. At 20 wk after initial presentation, the infant was weaned and the mother was euthanized. At necropsy, the mammary mass measured 3.5 × 2.5 × 1.5 cm, a 13-fold increase in volume since initial presentation. There was no evidence of metastasis in draining lymph nodes, lungs, or any other tissue examined. The tumor was composed of neoplastic stromal, glandular, and adipose tissues and was diagnosed as a malignant phyllodes tumor in light of its high stromal cellularity, high mitotic rate, and marked atypia. This tumor also exhibited liposarcomatous differentiation, which occurs frequently in malignant phyllodes tumors. To our knowledge, this report represents the first described case involving an NHP of a mammary tumor with characteristics consistent with human phyllodes tumors.


Subject(s)
Galago , Mammary Neoplasms, Animal/pathology , Phyllodes Tumor/veterinary , Animals , Female , Phyllodes Tumor/pathology , Pregnancy
7.
J Med Primatol ; 45(4): 198-201, 2016 08.
Article in English | MEDLINE | ID: mdl-27338233

ABSTRACT

BACKGROUND: An adult male galago (Otolemur garnettii) presented for fight wounds following pairing for breeding. Treatment was symptomatic with recovery. Following resolution, the animal re-presented and died, despite additional treatment. METHODS: Necropsy, histopathology, bacterial cultures, and 16S RNA sequencing. RESULTS: A large intrathoracic/intra-abdominal abscess due to Trueperella pyogenes was found at necropsy. CONCLUSIONS: T. pyogenes should be considered in abscesses/wounds of galagos.


Subject(s)
Abscess/veterinary , Actinomycetales Infections/veterinary , Arcanobacterium/isolation & purification , Galago , Abdominal Abscess/diagnosis , Abdominal Abscess/drug therapy , Abdominal Abscess/microbiology , Abdominal Abscess/veterinary , Abscess/diagnosis , Abscess/drug therapy , Abscess/microbiology , Actinomycetales Infections/diagnosis , Actinomycetales Infections/drug therapy , Actinomycetales Infections/microbiology , Animals , Anti-Bacterial Agents/administration & dosage , Arcanobacterium/genetics , Drug Therapy, Combination/veterinary , Male , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/genetics , Sequence Analysis, RNA , Thoracic Diseases/diagnosis , Thoracic Diseases/drug therapy , Thoracic Diseases/microbiology , Thoracic Diseases/veterinary
8.
Comp Med ; 65(5): 398-408, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26473343

ABSTRACT

Various immunohistochemical panels are used as aids to distinguish between primary hepatocellular malignancies and metastatic tumors and between benign lesions and carcinomas. We compared the immunohistochemical spectrum of hepatocellular lesions in mice with that of human hepatocellular carcinoma (HCC). Specifically, we compared the staining parameters of 128 murine foci of cellular alteration (FCA) and tumors (adenoma and HCC) from archival tissue blocks of 3 transgenic mouse models (LFABP-cyclin D1, Alb1-TGFß1, and LFABP-cyclin D1 × Alb1-TGFß1) with those of archival human HCC (n = 5). Antibodies were chosen according to their published performance and characterization in human hepatocellular tumor diagnosis and included: arginase 1 (Arg1), ß-catenin, glutamine synthetase (GS), glypican 3, hepatocyte paraffin 1 (HepPar1), and cytokeratin 19 (CK19). GS was the single best immunostain for identifying hepatocellular tumors in mice, with 100% positive staining. Data showed a trend toward loss of normal function (staining) with Arg1, with a higher percentage of positive staining in FCA than in adenomas and HCC. All FCA lacked murine ß-catenin nuclear translocation, which was present in 2 of the 7 adenomas and 22 of the 96 HCC tested. HepPar1 staining was lower than anticipated, except in trabecular HCC (16 of 22 samples were positive). Glyp3 stained very lightly, and only scattered CK19-positive cells were noted (4 of 44 cases of mouse trabecular HCC). Thus, GS appears to be the most useful marker for identifying neoplasia in the transgenic mouse models we tested and should be included in immunohistochemistry assessing hepatocellular neoplasia development.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Hepatocellular/metabolism , Glutamate-Ammonia Ligase/metabolism , Immunohistochemistry , Liver Neoplasms/metabolism , Animals , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Female , Genetic Predisposition to Disease , Humans , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Male , Mice, Inbred C57BL , Mice, Transgenic , Phenotype , Predictive Value of Tests , Species Specificity
9.
Nanomedicine ; 9(2): 257-63, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22772047

ABSTRACT

Gold nanoparticles are emerging as promising materials from which to construct nanoscale therapeutics and therapeutic delivery systems. However, animal studies have shown that gold nanoparticles modified with certain thiol monolayers such as tiopronin can cause renal complications and morbidity. Although these effects may be eliminated by coadsorbing small amounts of polyethylene glycol (PEG) onto the nanoparticle surface, PEG can also lower cellular internalization efficiency and binding interactions with protein disease targets, significantly reducing the potential for using gold nanoparticles as therapeutics. Using ICP-MS analysis of blood, urine, and several organs, we show in this article that glutathione-coated gold nanoparticles (1.2 nm ± 0.9 nm) cause no morbidity at any concentration up to and including 60 µM and target primary organs although providing gradual dissipation and clearance over time. This study suggests that glutathione may be an attractive alternative to PEG in the design of gold nanoparticle therapeutics. FROM THE CLINICAL EDITOR: This study describes the utility and toxicity of glutathione coated gold nanoparticles in comparison to PEGylated counterparts that are commonly used to increase "Stealth" properties and lower cytotoxicity. Too much PEG on the NPs can lead to lower cellular internalization efficiency and less efficient binding interactions with protein disease targets, significantly reducing the potential for using gold nanoparticles as therapeutics.


Subject(s)
Glutathione/toxicity , Gold/toxicity , Nanoparticles/toxicity , Animals , Erythrocyte Count , Glutathione/blood , Glutathione/chemistry , Glutathione/pharmacokinetics , Gold/blood , Gold/chemistry , Gold/pharmacokinetics , Kidney/drug effects , Kidney/metabolism , Leukocyte Count , Mice , Mice, Inbred BALB C , Nanoparticles/analysis , Nanoparticles/chemistry
10.
Clin Cancer Res ; 17(20): 6490-9, 2011 Oct 15.
Article in English | MEDLINE | ID: mdl-21878537

ABSTRACT

PURPOSE: Radiation therapy continues to be an important therapeutic strategy for providing definitive local/regional control of human cancer. However, oncogenes that harbor driver mutations and/or amplifications can compromise therapeutic efficacy. Thus, there is a need for novel approaches that enhance the DNA damage produced by ionizing radiation. EXPERIMENTAL DESIGN: A forward chemical genetic approach coupled with cell-based phenotypic screening of several tumor cell lines was used to identify a novel chemical entity (NCE) that functioned as a radiation sensitizer. Proteomics, comet assays, confocal microscopy, and immunoblotting were used to identify the biological target. RESULTS: The screening process identified a 5-((N-benzyl-1H-indol-3-yl)-methylene)pyrimidine-2,4,6(1H,3H,5H)trione as an NCE that radiosensitized cancer cells expressing amplified and/or mutated RAS, ErbB, PIK3CA, and/or BRAF oncogenes. Affinity-based solid-phase resin capture followed by liquid chromatography/tandem mass spectrometry identified the chaperone nucleophosmin (NPM) as the NCE target. SiRNA suppression of NPM abrogated radiosensitization by the NCE. Confocal microscopy showed that the NCE inhibited NPM shuttling to radiation-induced DNA damage repair foci, and the analysis of comet assays indicated a diminished rate of DNA double-strand break repair. CONCLUSION: These data support the hypothesis that inhibition of DNA repair due to inhibition of NPM shuttling increases the efficacy of DNA-damaging therapeutic strategies.


Subject(s)
DNA Breaks, Double-Stranded/drug effects , DNA Repair/drug effects , Neoplasms/drug therapy , Nuclear Proteins/metabolism , Radiation-Sensitizing Agents/pharmacology , Animals , Barbiturates/pharmacology , Cell Line, Tumor , DNA Damage/drug effects , Humans , Indoles/pharmacology , Mice , Mice, Nude , Molecular Chaperones/metabolism , Molecular Targeted Therapy , Neoplasms/metabolism , Nucleophosmin , Radiation Tolerance/drug effects , Random Allocation
11.
Respirology ; 15(1): 119-25, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20199636

ABSTRACT

BACKGROUND AND OBJECTIVE: The mechanism by which iodopovidone achieves pleurodesis is unknown. This study investigated whether iodopovidone is as effective as doxycycline in producing pleurodesis and whether systemic corticosteroids diminish its efficacy. METHODS: Four groups of seven New Zealand rabbits were assigned to the following intrapleural treatment groups: 2 mL of 2% iodopovidone, 2 mL of 4% iodopovidone, 2 mL of 4% iodopovidone plus 0.8 mg/kg triamcinolone intramuscularly weekly and 10 mL/kg doxycycline in 2 mL. Pleural fluid was collected 24, 48 and 72 h after intrapleural injections and analysed for WCC, protein and LDH levels. The rabbits were killed 2 weeks after the injections. Pleurodesis was graded macroscopically on a scale from 1 to 8. The degree of microscopic pleural fibrosis and pleural inflammation was graded from the HE stain slides. RESULTS: The mean volume of pleural fluid as well as the mean total WCC was significantly lower in the steroid-treated group than in the other groups. The degree of the resulting pleurodesis was similar in the 2% iodopovidone (7.00 +/- 1.29), 4% iodopovidone (7.71 +/- 0.76) and doxycycline (7.14 +/- 0.90) groups (P > 0.05) whereas the pleurodesis score of the steroid group (3.71 +/- 1.98) was significantly lower than all other groups (P < 0.05). The degree of microscopic pleural fibrosis and pleural inflammation was significantly lower in the steroid group than in the 2% iodopovidone or 4% iodopovidone group. CONCLUSIONS: Both 2% and 4% iodopovidone can induce pleurodesis as efficaciously as doxycycline in rabbits. Systemic corticosteroids significantly decrease the efficacy of iodopovidone in producing pleurodesis.


Subject(s)
Doxycycline/administration & dosage , Pleurodesis/methods , Povidone-Iodine/administration & dosage , Animals , Inflammation/chemically induced , L-Lactate Dehydrogenase/analysis , Leukocyte Count , Pleura/drug effects , Rabbits , Triamcinolone/administration & dosage
12.
FASEB J ; 23(9): 2986-95, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19395476

ABSTRACT

There is a need for novel strategies that target tumor vasculature, specifically those that synergize with cytotoxic therapy, in order to overcome resistance that can develop with current therapeutics. A chemistry-driven drug discovery screen was employed to identify novel compounds that inhibit endothelial cell tubule formation. Cell-based phenotypic screening revealed that noncytotoxic concentrations of (Z)-(+/-)-2-(1-benzenesulfonylindol-3-ylmethylene)-1-azabicyclo[2. 2.2]octan-3-ol (analog I) and (Z)-(+/-)-2-(1-benzylindol-3-ylmethylene)-1-azabicyclo[2.2.2]octan-3-ol (analog II) inhibited endothelial cell migration and the ability to form capillary-like structures in Matrigel by > or =70%. The ability to undergo neoangiogenesis, as measured in a window-chamber model, was also inhibited by 70%. Screening of biochemical pathways revealed that analog II inhibited the enzyme ENOX1 (EC(50) = 10 microM). Retroviral-mediated shRNA suppression of endothelial ENOX1 expression inhibited cell migration and tubule formation, recapitulating the effects observed with the small-molecule analogs. Genetic or chemical suppression of ENOX1 significantly increased radiation-mediated Caspase3-activated apoptosis, coincident with suppression of p70S6K1 phosphorylation. Administration of analog II prior to fractionated X-irradiation significantly diminished the number and density of tumor microvessels, as well as delayed syngeneic and xenograft tumor growth compared to results obtained with radiation alone. Analysis of necropsies suggests that the analog was well tolerated. These results suggest that targeting ENOX1 activity represents a novel therapeutic strategy for enhancing the radiation response of tumors.


Subject(s)
Endothelium, Vascular/cytology , Neovascularization, Pathologic/drug therapy , Protein Disulfide Reductase (Glutathione)/antagonists & inhibitors , Quinuclidines/pharmacology , Transcription Factors/antagonists & inhibitors , Cell Movement/drug effects , Cell Shape/drug effects , Cells, Cultured , Drug Evaluation, Preclinical , Endothelial Cells/drug effects , Endothelial Cells/physiology , Humans , Indoles , Membrane Proteins/antagonists & inhibitors , Neoplasms/blood supply , Neoplasms/therapy , Neovascularization, Pathologic/radiotherapy , Quinuclidines/therapeutic use
13.
Int J Cancer ; 122(12): 2851-7, 2008 Jun 15.
Article in English | MEDLINE | ID: mdl-18350568

ABSTRACT

Organ toxicity induced by chemotherapeutic drugs is a serious obstacle in the effective treatment of patients suffering from cancer and autoimmune disease. A strong association exists between pulmonary toxicity, particularly fibrosis, and chemotherapeutic drugs. Attempts have been made to identify compounds capable of suppressing fibrosis. In addition to its erythropoietic activity, erythropoietin (EPO) has been shown to have effects on nonhemopoietic cells. Therefore, we postulated that EPO may exert beneficial effects on lung tissue during chemotherapy. To test our hypothesis, we investigated pulmonary changes caused by bleomycin, a fibrosis-inducing agent, in animals treated with the drug alone and in combination with EPO. Fibrosis, cellular alterations and structural changes were assayed by blind analysis of the lung sections. A 6-fold decrease in the number of prominent endothelial cells--suspected to be indicative of cellular activation and inflammatory response--was observed in lung sections derived from mice treated with bleomycin and EPO compared to animals injected with bleomycin alone (p < 0.008). Additionally, there was twice the number of ICAM1-positive endothelial cells in animals treated with bleomycin alone compared with the number in the bleomycin and EPO-treated group (p < 0.05). Alveolar mononuclear phagocytic hyperplasia was reduced by as much as 100% in animals treated with bleomycin and EPO compared to animals treated with bleomycin alone (p < 0.03). Finally, a 5-fold decrease in interstitial fibrosis was observed in lung sections obtained from animals treated with bleomycin and EPO (p < 0.02). We conclude that EPO can ameliorate drug-induced fibrosis and endothelial damage caused by chemotherapeutic agents.


Subject(s)
Antineoplastic Agents/adverse effects , Bleomycin/adverse effects , Disease Models, Animal , Erythropoietin/pharmacology , Pulmonary Fibrosis/prevention & control , Animals , Female , Mice , Mice, Inbred C57BL , Pulmonary Fibrosis/chemically induced
14.
Transplantation ; 85(3): 331-7, 2008 Feb 15.
Article in English | MEDLINE | ID: mdl-18301328

ABSTRACT

BACKGROUND: Pancreatic islet transplantation has shown great success in the treatment of diabetic patients. However, the required immunosuppressive therapy exposes patients to serious side effects. METHODS: We have designed a novel five-component/three-membrane capsule and encapsulation system to protect the transplanted islet cells from immune system attack while allowing the influx of molecules and nutrients necessary for cell function/survival and efflux of the desired cellular product, specifically insulin, for making recipients healthy. RESULTS: We transplanted encapsulated canine pancreatic islets into the peritoneal cavity of pancreatectomized canines. Transplantation normalized fasting blood glucose levels in nine out of nine dogs for up to 214 days with a single transplantation. Retransplantation was assessed in three animals and encapsulated islets were effective in providing fasting glycemic control after the initial transplantation had run its course. No immunosuppression or anti-inflammatory therapy was used. CONCLUSION: This advancement in transplantation may lead to an alternative approach for islet transplantation treatment for diabetic patients. This approach may also benefit patients suffering from other hormone deficiency diseases including liver disease and Parkinson's disease.


Subject(s)
Diabetes Mellitus/surgery , Islets of Langerhans Transplantation/immunology , Islets of Langerhans Transplantation/methods , Pancreatectomy , Animals , Blood Glucose/metabolism , Diabetes Mellitus/metabolism , Diabetes Mellitus/pathology , Disease Models, Animal , Dogs , Female , Immunosuppression Therapy , Islets of Langerhans Transplantation/pathology , Male , Porosity , Transplantation, Homologous/immunology
15.
Ann Thorac Surg ; 78(4): 1397-402; discussion 1397-402, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15464504

ABSTRACT

BACKGROUND: Pulmonary vein isolation is a hallmark in current surgical ablation for atrial fibrillation. However, validation of isolation remains cumbersome. We evaluated electrophysiologic and not histologic means to test isolation. METHODS: In 16 mongrel dogs, robot-assisted epicardial beating-heart microwave ablation (FLEX 10) was performed around the pulmonary veins. Electrophysiologic isolation was tested by pacing at 4 times threshold values inside and outside the pulmonary veins (exit and entrance block). The histology of lesions was studied for transmurality and continuity of the lesion lines. In 5 dogs, lesions were studied at various time intervals. RESULTS: Histologic evaluation of the lesions showed incomplete (48% +/- 20%) circumferential myocardial damage in all dogs with acute lesions. Electrophysiologic evaluation showed completion of the box (entrance and exit block) in 8 dogs and in another 5 dogs after repeated ablation (p < 0.01 compared with histologic evaluation). Electrophysiologic evaluation of the dogs with chronic lesions showed completed lesions in 4 of 5 dogs directly after ablation. At follow-up (1 to 3 weeks), the isolations remained electrophysiologically complete. Histologic evaluation of the lesions 1 to 3 weeks after ablation showed complete (100%) circumferential lesions in all 4 dogs (p < 0.001 compared with the histology of dogs with acute lesions). CONCLUSIONS: Directly after treatment, ablation lesions are best evaluated electrophysiologically, because complete (transmural and circumferential) lesions are not shown by histologic evaluation in the acute stage. After 1 to 3 weeks, the histology is in accordance with the electrophysiology. To obtain a complete isolation, online electrophysiologic evaluation during pulmonary vein microwave ablation is necessary to optimize the results.


Subject(s)
Cardiac Pacing, Artificial , Catheter Ablation , Heart/physiopathology , Microwaves/therapeutic use , Myocardium/pathology , Pulmonary Veins/surgery , Animals , Catheter Ablation/adverse effects , Catheter Ablation/methods , Dogs , Heart/radiation effects , Heart Atria , Microwaves/adverse effects , Myocytes, Cardiac/pathology , Myocytes, Cardiac/radiation effects , Necrosis , Postoperative Period , Radiation Injuries/etiology , Radiation Injuries/pathology , Robotics
SELECTION OF CITATIONS
SEARCH DETAIL